background preloader

Strategic intelligence: COVID-19

Related:  Coronavirus COVID-19COVID-19 surveillanceRoundabout

Doctors say Trump takes steroid dexamethasone after oxygen dip The medical team treating Donald Trump, who tested positive for the novel coronavirus on Thursday, has said the president has “continued to improve” and could return to the White House as soon as Monday while adding he had been given oxygen and the steroid dexamethasone after his blood oxygen level dipped in recent days. The medical team addressed reporters on Sunday from Walter Reed National Military Medical Center, where Trump was hospitalised on Friday following the diagnosis, which came just more than a month before the presidential election on November 3. “Since we spoke last, the president has continued to improve. As with any illness, there are frequent ups and downs over the course,” Trump’s physician Dr Sean Conley said.

EURO_COVID19_Dashboard - PUBLIC Figures, colors and icons in country and territory lists Case totals include both probable and confirmed cases reported to WHO. 14-day incidence values represent incidence (# new cases reported) per 100 000 population over the past 14 days. Percentages indicate change in 14-day cumulative incidence as compared to 14 days ago: Reported Transmission Status Leverage Points: Places to Intervene in a System - The Solutions Journal In Brief Editor’s note: Donella Meadows’ Leverage Points is a classic reference for those seeking to implement change. As she tells it, Meadows was at a conference on global trade when it occurred to her that the participants were going about everything the wrong way. “These nice, liberal folks” were trying to control growth with adjustments that were “way too puny!” She marched up to a flip chart, tossed over a clean page, and wrote a list that later evolved into the twelve leverage points excerpted here. The list has proven influential to leaders across the globe and, by reprinting it, we hope it will help readers effectively address the world’s most pressing problems.

The coronavirus crisis as tipping point: communicating the environment in a time of pandemic Times of crisis can be moments of fear, in which the future becomes threatening and unknown. Moments of crisis can also be points of inflection: instructive opportunities to rethink old ways of behaving, to pause, re-evaluate, and choose new paths. In this essay, we conceptualise the coronavirus pandemic as such a point of inflection in mediatised discourse on the environment. We briefly examine here a range of mainly Australian media coverage of environmental issues during the COVID-19 pandemic, and we identify some of the key distinguishing framings of media reporting on the environment during this time. We examine media and environment during the pandemic through the conceptual lens of environmental communication, which like conservation biology, regards itself a ‘crisis discipline’ (Cox, 2007: 4), being fundamentally involved with the revealing and addressing of environmental harms. In this essay, we take the pulse of environmental communication under COVID-19.

esri As hundreds of millions of eyes stay glued to the rising toll and reach of the novel coronavirus disease 2019 (COVID-19), map-based dashboards have become a compelling, near real-time way to monitor the outbreak. They’ve also substantiated the message that everyone must take precautions and alter daily interactions. When the World Health Organization (WHO) declared COVID-19 a pandemic, director-general Tedros Adhanom Ghebreyesus warned that the situation would worsen. Yet, he noted, this is the first world pandemic that can be controlled, in part due to global connectivity and awareness. The controllability of COVID-19 can also be attributed to tools that quantify data inputs—and aggregate information about who and when in the context of where.

COVID-19 and global value chains: Policy options to build more resilient production networks COVID-19 is a global public health crisis with implications for all aspects of life. In this context, governments are pursuing measures to address health and safety that also have implications for international trade and investment. This note addresses questions related to the impact of COVID-19 on global value chains (GVCs), focussing on economic impacts and consequences for the organisation of production networks. It discusses policies that can help to promote security of supply and ensure a sustainable economic recovery. copy the linklink copied! COVID-19 has re-ignited an old debate about the supply chain risks associated with international production.

Michael O'Brien's no-confidence motion against 'dangerous' Daniel Andrews fails, Victorian COVID-19 inquiry extended - ABC News The Victorian Opposition Leader has labelled Premier Daniel Andrews "dangerous and arrogant" during a failed bid to oust him from office with a no-confidence motion in Parliament. Key points: A no-confidence motion brought against Victorian Premier Daniel Andrews has been easily defeated in State ParliamentVictorian Opposition leader Michael O'Brien brought the motion forward and labelled the Andrews Government "a danger to Victorians"Mr O'Brien accused the Government of a "litany of lies" during a scathing speech

Number of coronavirus (COVID-19) cases and risk in the UK Video: How to wash your hands properly Number of cases and deaths As of 9am on 27 April, there have been 719,910 tests, with 37,024 tests on 26 April. The National Map - Advanced Viewer USGS Home Contact USGS Search USGS Services Accessibility FOIA Privacy Policies and Notices U.S. Department of the Interior | U.S. Geological Survey URL: Page Last Modified: 22-Oct-18 Page Contact Information: The National Map

How can virtual health help expand capacity in the... by Felix Matthews, MD, MBA, managing director, and Urvi Shah, senior manager, Deloitte Consulting LLP The rapid expansion of the COVID-19 outbreak is threatening a possible surge in demand for both ambulatory and inpatient services. Areas likely to be impacted include infrastructure, workforce, and equipment. In terms of infrastructure, the US has about 46,000 medical intensive-care unit (ICU) beds already operating at or near full capacity. A moderate impact from the COVID-19 outbreak, with social-distancing measures in place, could still result in about 200,000 patients in need of hospitalization in an ICU, leaving the country unable to respond to the potential demand.1 Inpatient capacity exists but is unevenly distributed, and high-acuity inpatient beds and ICU spots remain scarce.